vs

Side-by-side financial comparison of CHAIN BRIDGE BANCORP INC (CBNA) and IRIDEX CORP (IRIX). Click either name above to swap in a different company.

IRIDEX CORP is the larger business by last-quarter revenue ($14.7M vs $14.7M, roughly 1.0× CHAIN BRIDGE BANCORP INC).

Suburban Bancorp, Inc. was a publicly traded multibank holding company headquartered in suburban Chicago. It was founded by Gerald F. Fitzgerald, father of former U.S. Senator Peter Fitzgerald, and majority owned by the Fitzgerald family. Bank of Montreal acquired Suburban Bancorp, Inc. by merger in 1994. Harris Bankmont, Inc., an American subsidiary of Bank of Montreal, merged with Suburban Bankcorp to expand the Harris Bank presence in the Chicago area. The all-stock deal was valued at $246...

IRIDEX Corporation is a global medical technology company that designs, manufactures and distributes advanced laser-based medical devices, primarily serving the ophthalmology and aesthetic medicine sectors. It supplies products to healthcare providers, clinics and medical facilities across North America, Europe, Asia Pacific and other regions, delivering minimally invasive solutions for eye disease treatment and cosmetic procedures.

CBNA vs IRIX — Head-to-Head

Bigger by revenue
IRIX
IRIX
1.0× larger
IRIX
$14.7M
$14.7M
CBNA

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CBNA
CBNA
IRIX
IRIX
Revenue
$14.7M
$14.7M
Net Profit
$5.3M
Gross Margin
37.2%
Operating Margin
45.6%
Net Margin
36.4%
Revenue YoY
-69.7%
Net Profit YoY
EPS (diluted)
$0.81

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBNA
CBNA
IRIX
IRIX
Q4 25
$14.7M
$14.7M
Q3 25
$13.1M
$12.5M
Q2 25
$12.6M
$13.6M
Q1 25
$14.5M
$11.9M
Q4 24
$12.7M
Q3 24
$16.7M
$11.6M
Q2 24
$12.6M
Q1 24
$11.8M
Net Profit
CBNA
CBNA
IRIX
IRIX
Q4 25
$5.3M
Q3 25
$4.7M
$-1.6M
Q2 25
$4.6M
$-994.0K
Q1 25
$5.6M
$-1.7M
Q4 24
$-834.0K
Q3 24
$7.5M
$-1.9M
Q2 24
$-2.7M
Q1 24
$-3.5M
Gross Margin
CBNA
CBNA
IRIX
IRIX
Q4 25
37.2%
Q3 25
32.1%
Q2 25
34.5%
Q1 25
42.5%
Q4 24
44.0%
Q3 24
37.3%
Q2 24
40.7%
Q1 24
37.9%
Operating Margin
CBNA
CBNA
IRIX
IRIX
Q4 25
45.6%
Q3 25
44.9%
-11.3%
Q2 25
45.8%
-6.9%
Q1 25
48.4%
-1.7%
Q4 24
-3.9%
Q3 24
56.3%
-16.1%
Q2 24
-20.9%
Q1 24
-28.0%
Net Margin
CBNA
CBNA
IRIX
IRIX
Q4 25
36.4%
Q3 25
35.8%
-12.6%
Q2 25
36.3%
-7.3%
Q1 25
38.6%
-14.2%
Q4 24
-6.6%
Q3 24
44.8%
-16.7%
Q2 24
-21.2%
Q1 24
-29.5%
EPS (diluted)
CBNA
CBNA
IRIX
IRIX
Q4 25
$0.81
Q3 25
$0.72
$-0.09
Q2 25
$0.70
$-0.06
Q1 25
$0.85
$-0.10
Q4 24
$-0.05
Q3 24
$1.64
$-0.12
Q2 24
$-0.16
Q1 24
$-0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBNA
CBNA
IRIX
IRIX
Cash + ST InvestmentsLiquidity on hand
$586.6M
$6.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$169.2M
Total Assets
$1.8B
$29.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBNA
CBNA
IRIX
IRIX
Q4 25
$586.6M
$6.0M
Q3 25
$395.7M
$5.6M
Q2 25
$377.3M
$6.8M
Q1 25
$629.2M
$7.2M
Q4 24
$2.4M
Q3 24
$639.8M
$3.9M
Q2 24
$4.1M
Q1 24
$5.4M
Total Debt
CBNA
CBNA
IRIX
IRIX
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$1.0M
Q3 24
$1.4M
Q2 24
Q1 24
Stockholders' Equity
CBNA
CBNA
IRIX
IRIX
Q4 25
$169.2M
Q3 25
$163.1M
$4.7M
Q2 25
$156.9M
$6.1M
Q1 25
$151.5M
$852.0K
Q4 24
$2.1M
Q3 24
$104.8M
$2.6M
Q2 24
$4.2M
Q1 24
$6.5M
Total Assets
CBNA
CBNA
IRIX
IRIX
Q4 25
$1.8B
$29.2M
Q3 25
$1.5B
$28.4M
Q2 25
$1.4B
$31.6M
Q1 25
$1.7B
$34.2M
Q4 24
$29.1M
Q3 24
$1.6B
$30.2M
Q2 24
$31.2M
Q1 24
$34.1M
Debt / Equity
CBNA
CBNA
IRIX
IRIX
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.48×
Q3 24
0.53×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBNA
CBNA
IRIX
IRIX
Operating Cash FlowLast quarter
$15.6M
Free Cash FlowOCF − Capex
$11.5M
FCF MarginFCF / Revenue
78.1%
Capex IntensityCapex / Revenue
28.0%
Cash ConversionOCF / Net Profit
2.92×
TTM Free Cash FlowTrailing 4 quarters
$17.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBNA
CBNA
IRIX
IRIX
Q4 25
$15.6M
Q3 25
$2.8M
$-1.2M
Q2 25
$3.4M
$-397.0K
Q1 25
$3.1M
$-1.1M
Q4 24
$-1.2M
Q3 24
$-3.1M
Q2 24
$-1.3M
Q1 24
$-1.6M
Free Cash Flow
CBNA
CBNA
IRIX
IRIX
Q4 25
$11.5M
Q3 25
$2.5M
$-1.2M
Q2 25
$2.5M
$-410.0K
Q1 25
$1.4M
$-1.2M
Q4 24
$-1.2M
Q3 24
$-3.1M
Q2 24
Q1 24
$-1.7M
FCF Margin
CBNA
CBNA
IRIX
IRIX
Q4 25
78.1%
Q3 25
18.7%
-9.4%
Q2 25
20.0%
-3.0%
Q1 25
9.8%
-9.8%
Q4 24
-9.8%
Q3 24
-26.5%
Q2 24
Q1 24
-14.0%
Capex Intensity
CBNA
CBNA
IRIX
IRIX
Q4 25
28.0%
Q3 25
2.5%
0.1%
Q2 25
6.5%
0.1%
Q1 25
11.6%
0.1%
Q4 24
0.1%
Q3 24
0.0%
Q2 24
0.0%
Q1 24
0.0%
Cash Conversion
CBNA
CBNA
IRIX
IRIX
Q4 25
2.92×
Q3 25
0.59×
Q2 25
0.73×
Q1 25
0.55×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons